Search Results for 'gemcitabine cisplatin'

Discussion Board Forums Search Search Results for 'gemcitabine cisplatin'

Viewing 15 results - 241 through 255 (of 676 total)
  • Author
    Search Results
  • gavin
    Moderator

    Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma

    https://clinicaltrials.gov/ct2/show/NCT02631590

    gavin
    Moderator

    A Study to See the Effects That a New Combination of the Three Drugs, Nab-paclitaxel, Gemcitabine, and Cisplatin Has on Biliary Tract Cancer

    https://clinicaltrials.gov/ct2/show/NCT02632305

    #90727

    Thank you so much Marion and Lainy. His diagnosis and treatment are taking place here in Thomasville, Georgia. He did get a 2nd opinion from Moffit Cancer Center in Tampa. They confirmed original diagnosis and agreed with the regiment of gemcitabine and cisplatin. He has also been seeing a pain management specialist because his pain is a major issue. The doctors, both at Moffit and here, told us that the chemo won’t cure him, but that it would hopefully shrink the tumor to relieve the pain. So far, he can control pain as long as he takes his pain meds every 4 hours. If he goes longer than that, the pain is back and usually a much worse pain.

    There are more tests and scans planned for February when he finishes this first regiment ( 8 cycles) of chemo to see if the tumor has shrunk.

    #90726
    marions
    Moderator

    sharonandphil…..so sorry to hear of the diagnoses. Our members are very familiar with this cancer and will stand by you and support you all the way. You will learn that you have come to the right place and that many others are in a similar situation. I assume your husband’s regimen consists of gemcitabine and cisplatin, which is considered first line of treatment for this cancer. Hoping for others to come forward and share their own experiences with you as well. Stay hopeful, miracles do happen.
    Hugs,
    Marion

    #90616

    In reply to: Chipsa Hospital

    marions
    Moderator

    Good points, Daisy. I agree in that there is plenty to dislike about pharmaceutical companies. Medicine is a business and those investing in these companies are less likely interested in the health of patients, but rather they expect a return on their money.

    However; if indeed many people with the same cancer are cured with a treatment offered in a private clinic, which require a substantial amount of money as well, then of course, we would have the Holy Grail of cancer treatment. But, this is not so.

    Our bodies are complex, cells are complex, cells dividing uncontrollable are complex. Years and years of cancer research resulted in some advances, but as a whole, cancer continues to kill many people.

    Gem/Cis does not provide a cure, but it is the largest study ever conducted on a large group of people comparing one group treated with Gemcitabine only to another group receiving the combination of Gemcitabine and Cisplatin. It is not considered a “curative” regimen in fact, as you know, other than surgery removing the entire tumor, we don’t have curative treatments. But, for many, this cancer can be held back and can be viewed as similar to that of a chronic disease
    Ultimately, patients have a right to make choices including considering that of Quantity of Life vs. Quality of Life.

    Hugs,
    Marion

    #11917
    irenel
    Member

    In 2013 I was diagnosed with Autoimmune Hepatitis/Cirrhosis. I never had any symptoms and was happily living my live feeling healthy until June 2015. My ultrasound showed a 1.4 cm intrahepatic lesion. This quickly led to CT scans, MRIs, PET scans and a liver resection on July 9, 2015 (my 78th birthday) for an isolated cholangiocarcinoma lesion. The surgeon said the margins were clean and there was no evidence of other diseased areas. Four months later on my follow up MRI there are 5 new lesions all under 1cm in size. I can’t believe how quickly this alien growth is taking over! I’m going to see the radiation oncologist this afternoon to discuss Radiofrequency Ablation which will probably be followed by chemo- Gemcitabine and Cisplatin (forever, they say).

    All of this is being done at Jefferson University Hospital in Philadelphia. Is there anyone else in this group being treated there?

    I’m happy to have found this group and look forward to reading your comments and your stories.

    #90388

    In reply to: New Member

    scott-sibley
    Member
    marions wrote:
    Scott….welcome and yes, we would prefer to meet under different circumstances, but here we are and happy for it. Most likely you will receive Gemcitabine and Cisplatin, which is considered standard of care for our cancer and is discussed many times on this site. For any questions you may have, be assured that someone with similar experience will share thoughts, ideas and experiences with you. My first question: Do you have a port installed?
    Good luck tomorrow and please stay in touch. We are in this together.
    Hugs,
    Marion

    I do not have a port installed, also, I don’t know what that is…..
    In all honesty, I’ve done minimal research on cancer the last 2 months. The only stuff I know is what the doctors told me.

    Scott

    #90387

    In reply to: New Member

    marions
    Moderator

    Scott….welcome and yes, we would prefer to meet under different circumstances, but here we are and happy for it. Most likely you will receive Gemcitabine and Cisplatin, which is considered standard of care for our cancer and is discussed many times on this site. For any questions you may have, be assured that someone with similar experience will share thoughts, ideas and experiences with you. My first question: Do you have a port installed?
    Good luck tomorrow and please stay in touch. We are in this together.
    Hugs,
    Marion

    #11847
    jrbobdobbs
    Member

    Hello,
    I originally posted back in March to this remarkable site to hear from others with more experience treating CC. My now 80 year-old mother in law was diagnosed in February of 2015 with likely CC (true origin unknown). CT at that time found 2 tumors on her liver, one 3 cm and one 5 cm. Cancer stage 4 and biopsy showed high grade, poorly differentiated cells. No spread of disease detected outside of the liver.
    She started treatment with Gemcitabine and Abraxane, and then quickly switched to Gem/Cis , which she initially did fairly well on; tumors shrank after a few months. However, Gem/Cis was too the side effects were too rough, quality of life not good, and for the past 5 months or so her team has maintained her on only Gemcitabine, dropping the cisplatin . The main side-effect has been fatigue, lack of appetite, some weight loss, with bouts of neutropenia, a few hospitalizations with pneumonia (x3). Tumors are located peripherally, so no jaundice, etc. Liver enzymes within reason, hematocrit around 27 and stable, white count back up to normal between infusions.

    Now after 7 months of on Gemcitabine, the tumors have returned. Our oncologist thinks Gem no longer effective. She is consulting with both Mayo clinic and Dana Farber to get additional opinions as to what to do next. Xeloda (capecitabine) seems like the best option to our onc. . That, or discontinue chemo in favor of better quality of life. Some discussion of “targeted therapies” as a possible option.

    Our Oncologist wonders if continued chemotherapy is the best option at this point, since quality of life is the primary goal, from the beginning of treatment until now. My mother in law and her husband of more than 50 years think that maybe if she can suffer through a bit longer on chemo the cancer will finally be cured and this whole difficult trial will be over. She has been told that treatment is palliative, by her medical team and by her kids, but this is a very difficult thing to comprehend and really understand.

    This is just my best quick sketch of this case. Any ideas would be very helpful, and let me know if there is anything important I’ve left out that would help us get better advice from this collective source of knowledge.

    Yours,
    Bob

    marions
    Moderator

    Studies are underway to determine the effectiveness of radiation in Cholangiocarcinoma. We should soon receive data derived from a clinical research study treating unresectable intrahepatic CCA treated with Gemcitabine and Cisplatin with added radiation treatment.
    https://clinicaltrials.gov/ct2/show/NCT02200042

    A retrospective study (evaluating response to a previously treated patient group) confirmed that larger tumors not eligible for surgical resection and combined with higher doses of radiation show equal response rates to those with surgical resection.
    “Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis”

    Due to Journal of Clinical Oncology proprietary rights, I am unable to post neither the link to the abstract nor am I able to download the publication on this site.

    However; anyone can sign up with PATIENT ACCESS and request the information with this link:
    https://s100.copyright.com/AppDispatchServlet?publisherName=ASCO&publication=jco&title=Ablative%20Radiotherapy%20Doses%20Lead%20to%20a%20Substantial

    To learn more about the effectiveness of higher dose radiation, you may want to download this video from our site:
    http://cholangiocarcinoma.org/new-upcoming-webinar-the-emerging-role-of-radiation-for-intrahepatic-cholangiocarcinoma-higher-doses-lead-to-improved-survival/

    Hugs,
    Marion

    #89491
    marions
    Moderator

    What differentiates the TAPUR study from that of the NCI MATCH study?

    Answer: tissue sample.
    TAPUR accepts previously collected biopsy analysed by a certified lab
    MATCH requires a fresh biopsy

    2nd noticeable difference:
    MATCH is coordinating treatments with physicians in community centers affiliated with research programs. Please see map:
    http://ncorp.cancer.gov/findasite/map.html

    TAPUR – regardless of physician’s location or affiliation – they can request study participation for their patients
    ASCO will collaborate and share data with the Netherlands Center for Personalized Cancer Treatment, which is conducting a clinical trial using a very similar study protocol.

    TAPUR study is expected to launch January or February 2016
    MATCH has similar date.
    Both studies require: patients must have failed standard of care.

    Still to investigate: Is Gemcitabine/Cisplatin “standard of care” of is it “preferred care”?
    If so, then I would assume that patients can have failed on Gemzar or Gemcitabine only and still qualify for this trial. I will look into this.

    These companies are providing drugs (free of charge) to the patient via the prescribing physician:
    AstraZeneca
    Bristol-Myers Squibb
    Eli Lilly and Company
    Genentech
    Pfizer

    Noticeably absent is MERCK, but I have been told of ongoing negotiations between ASCO and Merck.

    The mutations addressed with available targeted drugs:

    Afatinib* EGFR activating mutations

    Afatinib* HER2 activating mutations

    Crizotinib ALK rearrangement

    AZD9291 EGFR T790M mutations and rare EGFR activating mutations

    Crizotinib ROS1 translocations

    Dabrafenib and trametinib BRAF V600E and V600K mutations

    Trametinib BRAF fusions or non-V600E, non-V600K BRAF mutations

    TDM1 HER2 amplification

    VS-6063 NF2 loss

    Sunitinib CKIT mutations

    Both, mutations and targeted drugs will continue to develop.
    Please discuss with physician.
    Marion

    #90025
    marions
    Moderator

    A brief update:
    What differentiates the TAPUR study from that of the NCI MATCH study?

    Answer: tissue sample.
    TAPUR accepts previously collected biopsy analysed by a certified lab
    MATCH requires a fresh biopsy

    2nd noticeable difference:
    MATCH is coordinating treatments with physicians in community centers affiliated with research programs. Please see map:
    http://ncorp.cancer.gov/findasite/map.html

    TAPUR – regardless of physician’s location or affiliation – can request study participation for their patients
    ASCO will collaborate and share data with the Netherlands Center for Personalized Cancer Treatment, which is conducting a clinical trial using a very similar study protocol.

    TAPUR study is expected to launch January or February 2016
    MATCH has similar date.
    Both studies require: patients must have failed standard of care.

    Still to investigate: Is Gemcitabine/Cisplatin “standard of care” of is it “preferred care”?
    If so, then I would assume that patients can have failed on Gemcitabine or Gemzar (single agents) only and still qualify for this trial. I will look into this.

    Both, mutations and targeted drugs will continue to develop.
    Please discuss with physician.
    Marion

    #90090

    In reply to: Update

    kernos
    Member

    Thanks Lainy and Marion

    Lainy the registrar said it was a common occurrence and I did some reading up on it and those cancer cells are tricky little buggers. I’m probably putting to much importance in the tumor markers, they make it feel like I had 3 months of chemo for nothing.

    Marion I’ve changed from Cisplatin to Carboplatin and still on the Gemcitabine. My oncologist warned me again about the extremities danger when I reached cycle 6 as I’m also a type 2 diabetic. My podiatrist tested for nerve damage and found a deterioration in my mid level nerves I think it was (tuning fork test) whilst still in the good range it was significant enough for them to change to head of any complications. My podiatrist will now test every 6 weeks when I see her.

    As for genetic testing, I’m not sure how common that is here yet I think it is only done in one place in the country but I’m not sure. I did get accepted for a trial that involved genetic testing of my biopsy if it was still viable. The trial isn’t aimed at current patients but the chance of having the tumor genetically identified is a possibility.

    The trial is very popular and the lab doing the testing is doing it free of charge so it’s low priority, my oncologist is chasing them up to see if my results are back. If they have trouble nailing my treatment down it will be an option I will pursue I think.

    My main priority atm is getting my head on right, I dug myself a hole on diagnosis then climbed in and pulled the dirt on top of me like a blanket. I started digging out a few weeks ago but it’s taking time. I haven’t been looking after my diabetes or cancer and that wont help anyone.

    Having here to come and vent is a big part of getting my head straight so thank you for everything.

    Tony

    gavin
    Moderator

    [Gemcitabine in Combination with Cisplatin in Patients with Unresectable Advanced or Recurrent Biliary Tract Cancer-A Multicenter Prospective Observational Study in Fukuoka].

    http://www.ncbi.nlm.nih.gov/pubmed/26489546

    #11803
    dmr1965
    Member

    Hello. Like so many on here, I have had many adventures learning about this disease and trying to find treatment. I was living in upstate New York when it all began. I was 49 years old.

    It started in November or December of 2014. I had a lot of itching of my scalp and other sensitive areas but no sign of any skin conditions. I had gone to urgent care for very bad sinus swelling and mentioned the itching. The doctor urged me to see my primary care physician, because that itching could be caused by liver problems. I was leaving shortly after for a week out of

    the country, so I was given antihistamines to try to counter the itch, which became unbearable. As I became more itchy, I also became jaundiced and noticed my urine getting darker.

    After I came home, I ended up going to the ER at Saratoga Hospital, and things moved pretty quickly thereafter. I had a CT scan, then, after consulting my gastroenterologist, I had an MRCP, followed by an endoscope, where they did a brushing, and inserted a plastic stent into the blockage in my bile duct. This was the first time the C-word was uttered.

    I was officially diagnosed with a Klatskins tumor on February 4th, 2014 at Albany Medical Center (AMC). I had two biliary stents/drains installed, and also underwent an unsucessful resection/exploratory surgery. They had a very hard time getting the left stent installed. It ended up taking three separate attempts. When the doctor stopped me in the hall on a walk and said he
    was not confident of more than a 50% chance of success, I wish I’d have stopped there and started doing a lot of research on hospitals and treatments first, but I was just trusting what the doctors there had to say. By the way, besides our initial consultation, that brief moment was one of the few discussions I had with that surgeon. After the surgery, I had an infection get into the blood and ended up in ICU on a ventilator. After finally leaving the hospital after three weeks, I was soon back
    with another infection that had me in the hospital for another week. Both my surgeon and the oncologist that I saw at Albany

    Med were very much gloom and doom. They advocated standard chemo and radiation and getting on the liver transplant list and hoping for the best. They estimated that would buy me six months to a year.

    During this time, we were doing a lot of our own research, as we didn’t like the negative attitude or gloomy conclusions. The surgeon generally argued against everything we asked him about, or was very negative about it. Sitting at AMC, watching infomercials for Cancer Treatment Centers of America (CTCA) I decided to give them a call. But first I looked into MD Anderson in Houston and their pencil-beam radiation. They said they’d just do IMRT for me. That was my first introduction to the fact that insurance would dictate treatment as much as physicians.

    After some more insurance wrangling, I set out for CTCA in Atlanta. What was initially meant to be a 3 day evaluation turned into at least 2 weeks. The end result was that that they decided it may be resectable but were afraid it might be too far into liver. Recommended standard chemo, but thought a liver transplant center should evaluate/do surgery. They installed a PowerPort and did one round of chemo with Gemcitabine and cisplatin. This was the first actual treatment since diagnosis in February.

    They were not a lot of help in recommending facilities, but during our stay there we were also in contact with Sloan Kettering (not a transplant center, but since it was in NY I was going to get an opinion from them as well), and Mayo. I tried to get in on the gene theraphy trial being done at Mayo, but they did not have any openings for colangiocarcinoma patients. The CTCA doctor did give me information on a chemo trial, and the various hospitals that were participating. At around the same time, my uncle (more on family support later!) contacted the University of Colorado Hospital (UCH) at 10:30 at night, and someone not only answered the phone, they were very helpful. As they are a very well rated transplant facility, and Colorado is my home state, and the home of the aunt and uncle who were helping me out the entire time, we ended up heading out to Colorado. My case went before their liver board the day I went in for my first appointment and we had a plan of attack by noon.

    So, from late March to the present, I’ve been undergoing treatment at UCH. They were not very happy with my having had one round of chemo in Atlanta. We did the standard round of Gemcitabine and cisplatin infusion. The next step was a portal vein embolization to try to grow the left lobe of the liver prior to an attempted resection. It turned out that my left lobe did not grow. The resection was attempted, but the doctor did not like the condition of my liver (they didn’t like the scar tissue left by the previous surgery) and I was not handling the surgery well, so it was aborted. The hardest part for me was lying in the ICU the entire night thinking it was all over and succesful. I was not informed until the next morning, but we discussed moving right into a live donor transplant. In preparation for that we planned on oral chemo with Capecitabine/Xeloda and IMRT radiation. Following another insurance related delay of a week(insurance approved the radiation and the transplant, but denied the IMRT! The hospital filed an expidited appeal but heard nothing back) we changed the radiation to 3D Conformal and I started this Monday, October 19, 2015. I have a donor lined up who is undergoing testing now.

    Wisdom I’ve gained along the way:

    Don’t get enamored with any particular technology.

    You have to do your own legwork/research. Find any resources for your type of cancer. Get a
    second, third, fourth opinion.

    The cancer centers heavily advertise fancy new technology/treatments, but you likely won’t get it.
    You’ll likely get the standard approved (by the insurance companies) chemo and radiation for your type of cancer, and surgery.

    Don’t get enamored with a particular facility. Don’t accept your initial surgeon’s gloomy reaction, if they have one.

    Get as munch info as possible before surgery.

    Stay positive when things go wrong, or not as expected.

    Even surgeons can get their hopes up for a procedure, only to have things go wrong.

    Doctors and hospitals don’t seem to like the way other doctors and hospitals do things – Not Done Here Syndrome. There is no consensus on things like how often biliary drain tubes should be replaced, if/how often they should be flushed, if they should be covered with dressings/Tegaderm film…

    Keep moving! Even if all you can do is walk, do it!

    Family/friend support is invaluable. You need caregivers. Don’t try to do it all on your own.

Viewing 15 results - 241 through 255 (of 676 total)